Nih

Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.

RFA-AR-27-002: HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)

The NIH HEAL Initiative seeks a U24 Data Coordination and Integration Center to harmonize and integrate pain-related datasets, including INTERACT consortium outputs, to support evidence-driven pain research and secondary analysis.

Status: Open Type: Grant Deadline: Oct 2, 2026 Location: United States

RFA-AT-25-003: HEAL Initiative Pain Research Enhancement Program (PREP) for R15 Institutions

A NIH HEAL NOFO under R15 to fund basic and mechanistic pain research led by eligible undergraduate-focused, health professional, and graduate institutions, with emphasis on student engagement and interdisciplinary collaboration with NIH partner institutions.

Status: Open Type: Grant Amount: up to $375,000 direct costs requested for entire project period Deadline: Oct 27, 2026 Location: United States

RFA-CA-24-026: National Cancer Institute Youth Enjoy Science Research Education Program (R25)

NIH R25 funding for institutions that design middle-school to undergraduate cancer research education programs, requiring research experiences, curriculum/method development, and outreach.

Status: Open Type: Grant Amount: Maximum $400,000 direct costs per year; project period up to 5 years Deadline: Sep 28, 2026 Location: United States

RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.

Status: Open Type: Grant Amount: $74,500,000 total program funding in the FY2027 notice, with up to 7 awards Deadline: Sep 18, 2026 Location: United States

RFA-CA-27-016: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)

NIH/NCI’s ETCTN NOFO seeks institutions that can lead early-phase cancer therapeutic trials within the NCI Cancer Therapy Evaluation Program, using the UM1 cooperative agreement model with a strong focus on trial activation, accrual, and mentorship for early career investigators.

Status: Open Type: Grant Amount: NIH intends to commit $11.8 million in FY 2027 to fund four to six awards Deadline: Jun 30, 2026 Location: United States and Canada

RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

NCI’s RFA-CA-27-021 supports advanced and widely adopted cancer informatics resources through U24 sustained-support awards, with $1.8 million committed in FY 2027 across two awards.

Status: Open Type: Grant Amount: $600,000 direct costs per year (up to), $1.8 million total committed for two awards Deadline: Jul 1, 2026 Location: United States

RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids

NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.

Status: Open Type: Grant Amount: NIH intends up to 4 awards and $2M total in FY 2026 Deadline: Nov 18, 2026 Location: United States and U.S. territories and possessions

RFA-DA-26-055: Accelerating the Pace of Substance Use Research Using Existing Data (R01)

NIH’s NIDA RFA-DA-26-055 supports R01 projects that use existing social, behavioral, administrative, and neuroimaging datasets to advance prevention, treatment, and service-delivery research on substance use, HIV, and related outcomes, without collecting primary data.

Status: Open Type: Grant Amount: NIDA intends to commit $2M in FY2026 for 2-4 awards and an additional $2M for 2-4 HIV-focused … Deadline: Jul 17, 2026 Location: United States and Global

RFA-DA-26-056: Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

NIDA's RFA-DA-26-056 funds R21 projects that use existing social, behavioral, administrative, and neuroimaging data to study substance use, related disorders, prevention, HIV, and service use without new data collection.

Status: Open Type: Grant Deadline: Jul 17, 2026 Location: United States

RFA-DA-27-004: BRAIN Initiative Theories, Models and Methods (R01, No Clinical Trials)

A 2026/2027 NIH BRAIN Initiative NOFO that funds computational, statistical, and data science tool development for analyzing complex multi-scale neural data with up to 15 awards per year from a $6M annual set-aside.

Status: Open Type: Grant Amount: NIH anticipates $6M/year for up to 15 awards Deadline: Oct 6, 2026 Location: United States